EPCAM+CD45+ cells in ascitic fluid of patients with ovarian cancer: a relationship with tumor marker levels and tumor grade
Purpose of the study: to assess the relationship between atypical/hybrid forms of EpCAM+CD45+ cells in ascitic fluid of ovarian cancer patients and the levels of cancer markers, such as CA125 and HE4, and the tumor grade. Material and methods. The study included 48 patients with newly diagnosed ova...
Saved in:
Main Authors: | A. V. Kozik, E. V. Kaigorodova, M. Yu. Grishchenko, S. V. Vtorushin, A. L. Chernyshova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Russian Academy of Sciences, Tomsk National Research Medical Center
2022-11-01
|
Series: | Сибирский онкологический журнал |
Subjects: | |
Online Access: | https://www.siboncoj.ru/jour/article/view/2306 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Heterogeneity of EpCAM-positive cells in low-grade serous ovarian carcinoma ascitic fluid: a clinical case
by: E. V. Kaigorodova, et al.
Published: (2022-01-01) -
Prognostic significance of atypical/hybrid forms of EpCAM+CD45+ cells in the blood of patients with endometrial cancer
by: E. V. Kaigorodova, et al.
Published: (2023-08-01) -
Dissimilar tumor cell populations in ascitic fluid of ovarian cancer patients
by: E. V. Kaigorodova, et al.
Published: (2020-04-01) -
Serous borderline ovarian tumors (clinical features, morphology, treatment)
by: I. Yu. Davydova, et al.
Published: (2014-07-01) -
Ascites as a subject of studies in ovarian cancer
by: A. B. Villert, et al.
Published: (2019-02-01)